These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9506592)

  • 1. No increase in soluble Fas and Fas ligand in Kawasaki disease: comment on the article by Nozawa et al.
    Koga M; Hasegawa S; Furukawa S
    Arthritis Rheum; 1998 Mar; 41(3):568-70. PubMed ID: 9506592
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
    Kim HY; Lee HG; Kim DS
    J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble Fas ligand and soluble Fas receptor in patients with chronic congestive heart failure.
    Gang L; Huhua L; Liangming W
    Chin Med Sci J; 2002 Dec; 17(4):258. PubMed ID: 12901518
    [No Abstract]   [Full Text] [Related]  

  • 4. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease.
    Taïeb J; Mathurin P; Poynard T; Gougerot-Pocidalo MA; Chollet-Martin S
    Lancet; 1998 Jun; 351(9120):1930-1. PubMed ID: 9654266
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis.
    Endo S; Inoue Y; Fujino Y; Yamada Y; Sato N; Wakabayashi G; Sakamoto T; Ishikura H; Tanaka T; Inada K; Sato S
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar serum levels of soluble forms of fas and fas ligand in cutaneous T cell lymphoma and benign lymphocyte-mediated dermatoses: relevancy for defective apoptosis hypothesis.
    Dereure O; Llanos F; Portales P; Clot J; Guilhou JJ
    J Invest Dermatol; 2002 May; 118(5):895-6. PubMed ID: 11982773
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis.
    Chang HY; Cooper ZA; Swetter SM; Marinkovich MP
    Arch Dermatol; 2004 Feb; 140(2):242-4. PubMed ID: 14967808
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
    Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J
    Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of soluble fas and soluble fas ligand in serum and peritoneal fluid of infertile patients with endometriosis.
    Linghu H; Xu X; Luo J; Zhuang L
    Chin Med Sci J; 2004 Mar; 19(1):56-9. PubMed ID: 15104227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-Fas ligand system in the peripheral blood of patients with renal diseases.
    Sato M; Konuma T; Yanagisawa N; Haizuka H; Asakura H; Nakashima Y
    Nephron; 2000 Jun; 85(2):107-13. PubMed ID: 10867515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and renal function in patients with acute respiratory distress syndrome.
    Kuo YH
    JAMA; 2003 Jul; 290(4):461; author reply 461-2. PubMed ID: 12876085
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of restenosis by serum levels of soluble Fas, Fas ligand and nuclear matrix protein before and after coronary intervention].
    Hara H; Sato R; Katagiri T; Hasegawa M
    J Cardiol; 2000 Feb; 35(2):89-93. PubMed ID: 10713929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased serum soluble Fas ligand in hyperthyroid Graves' disease].
    Takeda K; Ohara E; Kaneda T; Hashimoto K; Sasaki M
    Rinsho Byori; 1999 Oct; 47(10):961-5. PubMed ID: 10590671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
    Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
    Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
    Takubo T; Kumura T; Nishiki S; Kinoshita Y; Koh K; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
    Acta Haematol; 2000; 103(3):165-7. PubMed ID: 10940656
    [No Abstract]   [Full Text] [Related]  

  • 19. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C; Maurel J; Gallego R; Castells A; Longarón R; Marmol M; Sanz S; Molina R; Martin-Richard M; Gascón P
    Clin Cancer Res; 2005 Jul; 11(13):4770-4. PubMed ID: 16000573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
    Pignataro L; Arisi E; Sambataro G; Corsi MM
    J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.